The juggernaut that is the PBM industry continues to write the rules and the providers (pharmacies) and the payor (business and the government) pay the price. Eventually someone has to ask the obvious question: why are PBMs so profitable? The answer is lies in what they don’t tell us.
At least some business are interested in increasing transparency, though, as reported in StatNews.com’s Pharmalot View. For an interesting read, point your browser to The ‘gouge factor’: Big companies want transparency in drug price negotiations.
